[12] Patent
[11] Patent No.:GC0011374  
[45] Date of Publishing the Grant of the Patent: 1/Sep /2020                64/2020  
Number of the Decision to Grant the Patent:2020/171409
Date of the Decision to Grant the Patent:28/Jul/2020

[21] Application No.:GC 2015-29200

[22] Filing Date:8/4/2015

[30] Priority:

[33] State [32] Priority date [31] Priority No.
PCT
9/4/2014
PCT/CN2014/075011

[72] Inventors:1- Jinguang LIN،2- Xin LINGHU،3- Jeffrey STULTS،4- Hans IDING،5- Jing LI،6- Jianqian ZHANG

[73] Owner: GENENTECH, INC., 1 DNA Way, California 94080, South San Francisco, USA

[74] Agent: Abu-Gazaleh Intellectual Property L.L.C

  

 

  

[51]IPC:
Int. Cl.: A61K 31/506 (2006.01)

[56] Cited Documents:

-WO 2013/130976 A1 (ARRAY BIOPHARMA INC [US]; GENENTECH INC [US]; BLAKE JAMES F [US]; CHIC) 6 September 2013
-MU X Q ET AL.; PROCESS BIOCHEMISTRY 2011, vol. 46, no. 1, pages 233-239 D3: IKEMOTO N ET AL.; TETRAHEDRON 2003, vol. 59, no. 8, pages 1317-1325
 
Examiner: PH. Sarah A. AlGrainies

[54] PROCESS FOR THE MANUFACTURING OF MEDICAMENTS
[57] Abstract: The present invention provides a process for the manufacture of a compound of formula VIIIa and salts forms of VIIIa where Rc is an aryl sulfonic acid
No. of claims: 15     No. of figures: 2


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.